phosphoric acid, trisodium salt has been researched along with Kidney Diseases in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perkowska-Ptasińska, A; Rydzewski, A; Skuza, A; Szewczyk, K; Wasińska-Krawczyk, A | 1 |
| Adams, MA; Holden, RM; Hopman, WM; Johri, AM; Jozefacki, A; Shobeiri, NS; White, CA | 1 |
| Anastassopoulos, K; Cleveland, MV; Colman, S; Farraye, FA; Knight, T; Pelham, RW | 1 |
| Heher, EC; Humphreys, BD; Rennke, H; Thier, SO | 1 |
| Faber, MD; Jones, JK; Lamerato, L; Motsko, SP; Pezzullo, JC; Russmann, S | 1 |
| Brunelli, SM | 1 |
| Nagami, GT; Paige, NM | 1 |
| Rex, DK; Vanner, SJ | 1 |
| Abbott, KC; Hurst, FP | 1 |
| Amand, KS; Avigan, M; Green, L; Mackey, AC | 1 |
| Ehrenpreis, ED; Parakkal, D | 1 |
| Andrésdóttir, MB; Arnadóttir, M; Gudmundsson, H; Hardarson, S; Magnússon, T; Pálmadóttir, VK | 1 |
| Hendel, JW; Schmidt, PN | 1 |
| Du, H; Ehrenpreis, ED; Parakkal, D; Semer, R | 1 |
| Bourquin, V; Hadengue, A; Levy, M; Moll, S; Ponte, B; Zellweger, M | 1 |
| Thorp, ML; Weiss, J | 1 |
| Anyaegbu, E; Beck, A; Davis, TK; Hruska, K; Kniska, K | 1 |
| SELYE, H | 1 |
| Boyd, M; Choo, E; Risovic, V; Wasan, KM | 1 |
| Caswell, M | 1 |
| Carl, DE; Sica, DA | 1 |
| Brunelli, SM; Feldman, HI; Gupta, M; Latif, SM; Lewis, JD; Weiner, MG | 1 |
| Abbott, KC; Bohen, EM; Das, NP; Gao, SW; Hurst, FP; Oliver, DK; Osgard, EM | 1 |
| Ober, KM; Schneider, P; Ueberberg, H | 1 |
| Al-Bander, HA; Etheredge, SB; Humphreys, MH; Mock, DM; Morris, RC; Paukert, TT | 1 |
5 review(s) available for phosphoric acid, trisodium salt and Kidney Diseases
| Article | Year |
|---|---|
Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.
Topics: Adenoma; Administration, Oral; Biopsy; Cathartics; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Dose-Response Relationship, Drug; Evidence-Based Medicine; Humans; Hypophosphatemia, Familial; Kidney Diseases; Metabolic Diseases; Nephrocalcinosis; Phosphates; Preoperative Care; Risk Factors; Time Factors | 2008 |
Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis.
Topics: Administration, Oral; Cathartics; Humans; Kidney Diseases; Phosphates | 2009 |
Colon cleansing before colonoscopy: does oral sodium phosphate solution still make sense?
Topics: Administration, Oral; Canada; Cathartics; Clinical Trials as Topic; Colonoscopy; Humans; Kidney Diseases; Pharmaceutical Solutions; Phosphates; United States | 2009 |
Acute phosphate nephropathy.
Topics: Acute Disease; Administration, Oral; Biomarkers; Biopsy; Calcium Phosphates; Cathartics; Creatinine; Drug Labeling; Humans; Kidney; Kidney Diseases; Phosphates; Proteinuria; Risk Assessment; Safety-Based Drug Withdrawals; United States; United States Food and Drug Administration; Up-Regulation | 2009 |
[Phosphate nephropathy: how to avoid it?].
Topics: Aged; Biopsy; Cathartics; Colonoscopy; Female; Humans; Kidney Diseases; Phosphates; Switzerland | 2011 |
20 other study(ies) available for phosphoric acid, trisodium salt and Kidney Diseases
| Article | Year |
|---|---|
Phosphate nephropathy after administration of bowel purgative containing sodium phosphate - a case report.
Topics: Aged; Calcium Phosphates; Cathartics; Female; Humans; Kidney Diseases; Kidney Tubules; Phosphates | 2014 |
Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor?
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Creatinine; Diet; Dose-Response Relationship, Drug; ErbB Receptors; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Pilot Projects; Postprandial Period; Risk Factors; Vascular Calcification; Young Adult | 2016 |
A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study.
Topics: Acute Kidney Injury; Adolescent; Adult; Arrhythmias, Cardiac; Cathartics; Colitis, Ischemic; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Electrolytes; Gout; Heart Diseases; Humans; Incidence; Kaplan-Meier Estimate; Kidney Diseases; Middle Aged; Phosphates; Polyethylene Glycols; Product Surveillance, Postmarketing; Retrospective Studies; Seizures; Sulfates; Water-Electrolyte Imbalance; Young Adult | 2016 |
Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min.
Topics: Administration, Oral; Aged; Biomarkers; Cathartics; Colonoscopy; Creatinine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Phosphates; Polyethylene Glycols; Renal Insufficiency; Risk Factors | 2008 |
The top 10 things nephrologists wish every primary care physician knew.
Topics: Aluminum; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antacids; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Cathartics; Chronic Disease; Contraindications; Creatinine; Cyclosporine; Disease Progression; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Evidence-Based Medicine; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Magnesium; Nephrolithiasis; Nephrology; Phosphates; Primary Health Care; Proteinuria; Recombinant Proteins; Referral and Consultation; Tacrolimus; Urinalysis | 2009 |
Sodium phosphate tablets and acute phosphate nephropathy.
Topics: Acute Disease; Adult; Aged; Cathartics; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Tablets | 2009 |
Calcium phosphate nephropathy from colonoscopy preparations: effect of body weight.
Topics: Area Under Curve; Body Weight; Cathartics; Colonoscopy; Electrolytes; Humans; Kidney Diseases; Phosphates; Tablets | 2010 |
Incidence and outcome of acute phosphate nephropathy in Iceland.
Topics: Acute Disease; Aged; Cathartics; Colonoscopy; Female; Humans; Iceland; Incidence; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Phosphates; Retrospective Studies | 2010 |
[Modest risk of phosphate nephropathy by bowel cleansing].
Topics: Administration, Oral; Cathartics; Colonoscopy; Enema; Humans; Hyperphosphatemia; Kidney Diseases; Nephrocalcinosis; Phosphates; Polyethylene Glycols; Practice Guidelines as Topic; Renal Insufficiency; Risk Factors; Therapeutic Irrigation | 2010 |
Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration.
Topics: Adverse Drug Reaction Reporting Systems; Body Weight; Cathartics; Colonoscopy; Female; Humans; Kidney Diseases; Male; Phosphates; Retrospective Studies; Sex Factors; Tablets; United States; United States Food and Drug Administration | 2011 |
Acute phosphate nephropathy: a cause of chronic kidney disease.
Topics: Acute Disease; Aged; Cathartics; Colonoscopy; Creatinine; Female; Humans; Kidney Diseases; Phosphates; Renal Insufficiency, Chronic | 2011 |
Buyer beware! doctor be aware!: Questions.
Topics: Child; Colostomy; Constipation; Dialysis; Enema; Fecal Incontinence; Female; Humans; Hyperphosphatemia; Hypocalcemia; Kidney Diseases; Phosphates; Tetany | 2013 |
Humoral conditioning for the production of a suppurative, acute myocarditis by the oral administration of sodium phosphate.
Topics: Administration, Oral; Blood Vessels; Dihydrotachysterol; Humans; Hydrocortisone; Kidney Diseases; Myocarditis; Pharmaceutical Preparations; Phosphates; Vitamin D; Vitamins | 1958 |
Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Creatinine; Deoxycholic Acid; Drug Delivery Systems; Kidney Diseases; Lipids; Male; Micelles; Phosphates; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triglycerides | 2003 |
Bowel preparation with oral sodium phosphate and renal disease.
Topics: Administration, Oral; Enema; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphates | 2006 |
Acute phosphate nephropathy following colonoscopy preparation.
Topics: Acute Disease; Biopsy; Cathartics; Colonoscopy; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Middle Aged; Phosphates; Treatment Outcome | 2007 |
Risk of kidney injury following oral phosphosoda bowel preparations.
Topics: Administration, Oral; Adult; Aged; Case-Control Studies; Cohort Studies; Female; Humans; Intestines; Kidney; Kidney Diseases; Male; Middle Aged; Phosphates; Sensitivity and Specificity | 2007 |
Association of oral sodium phosphate purgative use with acute kidney injury.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cathartics; Cohort Studies; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Polyethylene Glycols; Regression Analysis; Retrospective Studies | 2007 |
Contribution to the phosphate-induced nephropathy in the dog. Comparative light and electron microscopic investigations on the proximal tubule after oral application of K2HPO4, Na2HPO4, KCl and NaCl.
Topics: Animals; Atrophy; Autopsy; Dogs; Kidney Diseases; Kidney Tubules, Proximal; Male; Microscopy; Microscopy, Electron; Phosphates; Potassium; Potassium Chloride; Potassium Compounds; Sodium Chloride | 1981 |
Coordinately increased lysozymuria and lysosomal enzymuria induced by maleic acid.
Topics: Acetylglucosaminidase; Acidosis, Renal Tubular; Animals; beta-Galactosidase; Dogs; Fanconi Syndrome; Female; Galactosidases; Glucuronidase; Hexosaminidases; Injections, Intravenous; Kidney Diseases; Kidney Function Tests; Maleates; Metabolic Clearance Rate; Muramidase; Phosphates | 1986 |